Pfizer Inc. (PFE)
Pfizer Inc. reported revenue of $62.58B for the fiscal year ended Dec 31, 2025, down 1.6% from $63.63B the year before. Net income was $7.77B, a net margin of 12.4% (prior year: $8.03B). At the end of that fiscal year the company reported total assets of $208.16B and shareholders' equity of $86.48B.
Revenue
$62.58B
−1.6% vs prior year
Net income
$7.77B
Net margin 12.4%
Diluted EPS
$1.36
USD per share
Total assets
$208.16B
At Dec 31, 2025
Equity
$86.48B
At Dec 31, 2025
Shares outstanding
5,700M
As of Oct 28, 2026
Explore Pfizer Inc.'s filings
- Revenue by year — annual and quarterly revenue with growth rates
- Income statement & cash flow — profit, margins, EPS and operating cash flow
- Balance sheet — assets, liabilities, equity, cash and debt
- SEC filings — 10-K and 10-Q filings with links to EDGAR
Latest SEC filings
- 10-QFiled Nov 3, 2026
- 10-QFiled Aug 4, 2026
- 10-QFiled May 5, 2026
- 10-KFiled Feb 26, 2026
- 10-QFiled Nov 4, 2025
- 10-QFiled Aug 5, 2025
Compare Pfizer Inc.
- MRKPFE vs MRK
- JNJJNJ vs PFE
Source: SEC EDGAR XBRL company facts for CIK 78003 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.